CDKN2A and neoplasm: Candidate gene-based studies have shown that hypermethylation of tumor suppressor genes, including p16, MGMT, RASSF1A, and APC, occurs early in neoplasia and rises with carcinoma development, implicating these processes in disease onset and progression [35].